Review



anti breast cancer susceptibility gene 1 brca1  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Novus Biologicals anti breast cancer susceptibility gene 1 brca1
    Fig. 3. Lacking the enzymatic activities of SMARCA2/4 extends the accumulation of γH2AX, Ring Finger Protein 8 (RNF8) and Breast <t>cancer</t> <t>susceptibility</t> <t>gene</t> 1 <t>(BRCA1).</t> HeLa cells were pre-treated with or without FHD286 (1 µM) or Compound 14 (1 µM)
    Anti Breast Cancer Susceptibility Gene 1 Brca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+breast+cancer+susceptibility+gene+1+brca1/pm39082357-72-32-41?v=Novus+Biologicals
    Average 93 stars, based on 9 article reviews
    anti breast cancer susceptibility gene 1 brca1 - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "SMARCA2 and SMARCA4 Participate in DNA Damage Repair."

    Article Title: SMARCA2 and SMARCA4 Participate in DNA Damage Repair.

    Journal: Frontiers in bioscience (Landmark edition)

    doi: 10.31083/j.fbl2907262

    Fig. 3. Lacking the enzymatic activities of SMARCA2/4 extends the accumulation of γH2AX, Ring Finger Protein 8 (RNF8) and Breast cancer susceptibility gene 1 (BRCA1). HeLa cells were pre-treated with or without FHD286 (1 µM) or Compound 14 (1 µM)
    Figure Legend Snippet: Fig. 3. Lacking the enzymatic activities of SMARCA2/4 extends the accumulation of γH2AX, Ring Finger Protein 8 (RNF8) and Breast cancer susceptibility gene 1 (BRCA1). HeLa cells were pre-treated with or without FHD286 (1 µM) or Compound 14 (1 µM)

    Techniques Used:



    Similar Products

    93
    Novus Biologicals anti breast cancer susceptibility gene 1 brca1
    Fig. 3. Lacking the enzymatic activities of SMARCA2/4 extends the accumulation of γH2AX, Ring Finger Protein 8 (RNF8) and Breast <t>cancer</t> <t>susceptibility</t> <t>gene</t> 1 <t>(BRCA1).</t> HeLa cells were pre-treated with or without FHD286 (1 µM) or Compound 14 (1 µM)
    Anti Breast Cancer Susceptibility Gene 1 Brca1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+breast+cancer+susceptibility+gene+1+brca1/pm39082357-72-32-41?v=Novus+Biologicals
    Average 93 stars, based on 1 article reviews
    anti breast cancer susceptibility gene 1 brca1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 3. Lacking the enzymatic activities of SMARCA2/4 extends the accumulation of γH2AX, Ring Finger Protein 8 (RNF8) and Breast cancer susceptibility gene 1 (BRCA1). HeLa cells were pre-treated with or without FHD286 (1 µM) or Compound 14 (1 µM)

    Journal: Frontiers in bioscience (Landmark edition)

    Article Title: SMARCA2 and SMARCA4 Participate in DNA Damage Repair.

    doi: 10.31083/j.fbl2907262

    Figure Lengend Snippet: Fig. 3. Lacking the enzymatic activities of SMARCA2/4 extends the accumulation of γH2AX, Ring Finger Protein 8 (RNF8) and Breast cancer susceptibility gene 1 (BRCA1). HeLa cells were pre-treated with or without FHD286 (1 µM) or Compound 14 (1 µM)

    Article Snippet: The following antibodies were purchased from their respective companies: anti-γH2AX (Novus, NB100-384), anti-RAD51 (Catalog Number: MA1-23271; Invitrogen, Carlsbad, CA, USA), anti-ring finger protein 8 (RNF8) (Catalog number: 14112-1-AP, Proteintech, Wuhan, Hubei, China), anti-breast cancer susceptibility gene 1 (BRCA1) (Catalog Number: NB100-404, Novus, Littleton, CO, USA), anti-SMARCA2 (Catalog number: HPA029981; Sigma, Louis, MO, USA).

    Techniques: